title: Which is the best radiographic protocol for a clinical trial of a structure modifying drug in patients with knee osteoarthritis?
authors.affiliation: Rheumatology Division, Indiana University School of Medicine, Indianapolis 46202-5100, USA.
authors.forename: Kenneth D
authors.initials: KD
authors.lastname: Brandt
authors.forename: Steven A
authors.initials: SA
authors.lastname: Mazzuca
authors.forename: Thierry
authors.initials: T
authors.lastname: Conrozier
authors.forename: Jane E
authors.initials: JE
authors.lastname: Dacre
authors.forename: Charles G
authors.initials: CG
authors.lastname: Peterfy
authors.forename: Diego
authors.initials: D
authors.lastname: Provvedini
authors.forename: Phillipe
authors.initials: P
authors.lastname: Ravaud
authors.forename: Alain
authors.initials: A
authors.lastname: Taccoen
authors.forename: Eric
authors.initials: E
authors.lastname: Vignon
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020370:Osteoarthritis, Knee / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D010147:Pain Measurement; D011859:Radiography / Q000379:methods*; D016059:Range of Motion, Articular / Q000187:drug effects* / Q000502:physiology; D012107:Research Design; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
chemical_list: D018501:Antirheumatic Agents